Skip to content

Apathy in patients with Parkinson*s disease and major depressive disorder, a structural brain imaging study using Voxel Based Morphometry

Apathy in patients with Parkinson*s disease and major depressive disorder, a structural brain imaging study using Voxel Based Morphometry - Imaging and Apathy in patients with Parkinson*s disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30824
Enrollment
120
Registered
2007-03-14
Start date
2007-09-17
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathological indifference

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Idiopathic Parkinson*s disease as defined by the criteria of the United Kingdom Parkinson*s Disease Brain Bank, regarding the inclusion of Parkinson*s disease patients (Hughes, Daniel et al. 1992). - Apathy as defined by a score equal or higher than four on the apathy subscale of the Neuro Psychiatric Inventory (NPI), regarding the apathy groups (Cummings, Mega et al. 1994; Cummings 1997). - Depression as defined by the criteria stated in the DSM-IV, regarding the depressed patients (DSM-IV 1994). - Informed consent.

Exclusion criteria

Exclusion criteria: - Other concurrent neurological diseases than PD. - Concurrent psychiatric diseases (e.g. dementia). - Use of psychopharmacological medication. - Abuse of alcohol and/or drugs. - Cognitive deterioration as operationalised by a score of

Design outcomes

Primary

MeasureTime frame
- Atrophic brain processes observed in all groups (both grey matter atrophy and white matter hyper-intensities), measured by Voxel Based Morphometry imaging. - Performance on neuropsychiatric and neuropsychological tests. - Correlation between the abovementioned points.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)